Randomized trial of gemcitabine plus docetaxel vs. docetaxel plus capecitabine in metastatic breast cancer in 1st and 2nd line patients.
Phase of Trial: Phase III
Latest Information Update: 01 May 2014
At a glance
- Drugs Capecitabine; Docetaxel; Gemcitabine
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 26 Nov 2008 Status changed from active, no longer recruiting to completed.
- 27 Dec 2007 The expected completion date for this trial is now Jun 2008 according to ClinicalTrials.gov.
- 06 Sep 2006 Status change
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History